QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-half of one redeemable warrant |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Page |
||||
1 |
||||
2 |
||||
3 |
||||
5 |
||||
6 |
||||
20 |
||||
25 |
||||
25 |
||||
25 |
||||
25 |
||||
26 |
||||
26 |
||||
26 |
||||
26 |
||||
26 |
||||
27 |
March 31, 2022 |
December 31, 2021 |
|||||||
(unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Forward Purchase Agreement (FPA) asset |
||||||||
Investment held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Due to related party |
||||||||
Promissory note—related party |
||||||||
Convertible promissory note |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 6) |
||||||||
Class A redeemable ordinary shares subject to possible redemption, $ authorized; |
||||||||
Shareholders’ Deficit |
||||||||
Preference shares, $ |
||||||||
Class B non-redeemable ordinary shares, $and outstanding at March 31, 2022 and December 31, 2021 |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Shareholders’ Deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
$ |
$ |
||||||
|
|
|
|
For the Three Months Ended March 31, 2022 |
For the Three Months Ended March 31, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expense) |
||||||||
Change in fair value of FPA |
( |
) | ( |
) | ||||
Change in fair value of warrant liabilities |
||||||||
Transaction costs allocable to warrant liabilities |
— | ( |
) | |||||
Change in fair value of convertible promissory note |
( |
) |
— |
|||||
Interest earned on investment held in Trust Account |
||||||||
Total Other income (expense), net |
$ | $ | ||||||
Net income |
$ |
$ |
||||||
Weighted average shares outstanding, Class A redeemable ordinary shares |
||||||||
Basic and diluted net income per share, Class A redeemable ordinary shares |
$ |
$ |
||||||
Weighted average shares outstanding, Class B non-redeemable ordinary shares |
||||||||
Basic and diluted net income per share, Class B non-redeemable ordinary shares |
$ |
$ |
||||||
Class A |
Class B |
Total |
||||||||||||||||||||||||||
Ordinary Share |
Ordinary Share |
Additional |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Paid-In Capital |
Deficit |
Deficit |
||||||||||||||||||||||
Balance as of January 1, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net incom e |
— | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2022 |
$ | $ | $ | $ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A |
Class B |
Total |
||||||||||||||||||||||||||
Ordinary Share |
Ordinary Share |
Additional |
Accumulated |
Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Paid-In Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance as of January 1, 2021 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
Accretion of Class A ordinary shares to redemption amount |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Net income |
— | — | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance as of March 31, 2021 |
$ | $ |
$ | $ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, 2022 |
For the Three Months Ended March 31, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Payment of formation costs through issuance of Class B ordinary shares |
||||||||
Interest earned on investment held in Trust Account |
( |
) | ( |
) | ||||
Change in fair value of FPA |
||||||||
Change in fair value of warrant liabilities |
( |
) | ( |
) | ||||
Change in fair value of convertible promissory note |
||||||||
Transaction costs allocable to warrant liabilities |
||||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ( |
) | ||||
Accrued expense s |
||||||||
Due to related party |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash held in Trust Account |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||||||
Proceeds from sale of Private Placement Warrants |
||||||||
Proceeds from the convertible promissory note - related party |
||||||||
Repayment of Sponsor loan |
( |
) | ||||||
Payment of offering costs |
( |
) | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net Change in Cash |
||||||||
Cash – Beginning of period |
||||||||
|
|
|
|
|||||
Cash – End of period |
$ |
$ |
||||||
|
|
|
|
|||||
Non-Cash investing and financing activities: |
||||||||
Offering costs paid through promissory note |
$ | $ |
||||||
|
|
|
|
|||||
Offering costs included in accrued offering costs |
$ | $ |
||||||
|
|
|
|
|||||
Deferred underwriting commissions charged to additional paid in capital |
$ | $ |
||||||
|
|
|
|
Gross proceeds |
$ | |||
Less: Proceeds allocated to Public Warrants |
( |
) | ||
Less: Class A ordinary shares issuance costs |
( |
) | ||
Add: Accretion of carrying value to redemption value |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ | |||
|
|
For the Three Months Ended March 31, 2022 |
For the Three Months Ended March 31, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net income per share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income |
$ | $ | $ | $ | ||||||||||||
Denominator |
||||||||||||||||
Weighted-average shares outstanding |
||||||||||||||||
Basic and diluted net income per share |
$ | $ | $ | $ |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the last reported sale price of the Class A ordinary shares for any sub-divisions, share dividends, reorganizations, recapitalizations and the like). |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the Reference Value equals or exceeds $ sub-divisions, share dividends, reorganizations, recapitalizations and the like); and |
• | if the Reference Value is less than $ sub-divisions, share dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
Level 3: | Unobservable inputs based on the assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description |
Level |
March 31, 2022 |
December 31, 2021 |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account – U.S. Treasury Securities Money Market Funds |
1 | $ | $ | |||||||||
FPA Asset |
3 | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant Liability – Public Warrants |
1 | $ | $ | |||||||||
Warrant Liability – Private Placement Warrants |
3 | $ | $ | |||||||||
Convertible promissory note – related party |
3 | $ | $ |
January 26, 2021 (Initial measurement) |
December 31, 2021 |
March 31, 2022 |
||||||||||
Unit price |
$ | $ | $ | |||||||||
Term to initial Business Combination (in years) |
||||||||||||
Volatility |
% | % | % | |||||||||
Risk-free rate |
% | % | % | |||||||||
Dividend yield |
% | % | % |
Private Placement |
Public |
Total Warrant Liabilities |
||||||||||
Fair value as of January 1, 2022 |
$ | $ | — | $ | ||||||||
Change in fair value-Private Warrants |
— | |||||||||||
Fair value as of March 31, 2022 |
$ | $ | — | $ |
Private Placement |
Public |
Total Warrant Liabilities |
||||||||||
Fair value as of January 1, 2021 |
$ |
— |
$ |
— |
$ |
— |
||||||
Initial measurement on January 26, 2021 |
||||||||||||
Transfer to Level 1 |
— | ( |
) | ( |
) | |||||||
Change in fair value-Private Warrants |
( |
) | — | ( |
) | |||||||
Fair value as of March 31, 2021 |
$ | $ | — | $ |
Forward Purchase Units |
||||
Fair value as of January 1, 2022 |
$ | ( |
) | |
Change in fair value |
||||
Fair value as of March 31, 2022 |
$ | ( |
) |
Forward Purchase Units |
||||
Fair value as of January 1, 2021 |
$ | |||
Initial measurement on January 26, 2021 |
||||
Change in fair value |
( |
) | ||
Fair value as of March 31, 2021 |
$ |
March 31, 2022 |
February 14, 2022 |
|||||||
Stock price |
$ |
$ |
||||||
Weighted time to conversion (in years) |
||||||||
Volatility |
% |
% | ||||||
Risk-free rate |
% |
% |
Convertible Promissory Note |
||||
Fair value as of January 1, 2022 |
$ | |||
Proceeds received through Convertible Promissory Note on February 14, 2022 |
||||
Change in fair value |
||||
Fair value as of March 31, 2022 |
$ |
No. |
Description of Exhibit | |
31.1* | Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1** | Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB* | Inline XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* | Filed herewith. |
** | Furnished herewith. |
Date: May 13, 2022 | PRIMAVERA CAPITAL ACQUISITION CORPORATION | |||||
By: | /s/ Tong Chen | |||||
Name: | Tong Chen | |||||
Title: | Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer) |